Psychometric Validation of the Growth Hormone Deficiency-Child Impact Measure (GHD-CIM)
In: PharmacoEconomics - Open, Jg. 5 (2021-01-12), S. 505-518
Online
unknown
Zugriff:
Objective The aim of this study was to perform psychometric testing of the Growth Hormone Deficiency-Child Impact Measure (GHD-CIM): a patient-reported outcome (PRO) for children with GHD aged 9 to 0.70), as was test–retest reliability for the SWB, EWB and overall (above 0.70). At least one convergent validity hypotheses for each domain and overall was proven (r > 0.40). Known-groups validity hypotheses for the EWB and SWB domains were significant (p
Titel: |
Psychometric Validation of the Growth Hormone Deficiency-Child Impact Measure (GHD-CIM)
|
---|---|
Autor/in / Beteiligte Person: | Bushnell, Donald M. ; Vad, Knud ; Michael Højby Rasmussen ; Brod, Meryl ; Bedoin, Jacques ; Alolga, Suzanne ; Maniatis, Aristides |
Link: | |
Zeitschrift: | PharmacoEconomics - Open, Jg. 5 (2021-01-12), S. 505-518 |
Veröffentlichung: | Springer Science and Business Media LLC, 2021 |
Medientyp: | unknown |
ISSN: | 2509-4254 (print) ; 2509-4262 (print) |
DOI: | 10.1007/s41669-020-00252-5 |
Schlagwort: |
|
Sonstiges: |
|